Docherty, K. F. and Petrie, M. C. (2022) Sodium-glucose cotransporter 2 inhibitors as a treatment for heart failure. Heart, 108(4), pp. 312-320. (doi: 10.1136/heartjnl-2020-318658) (PMID:34127540)
![[img]](https://eprints.gla.ac.uk/style/images/fileicons/text.png) |
Text
241933.pdf - Accepted Version Available under License Creative Commons Attribution Non-commercial. 521kB |
Abstract
No abstract available.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Docherty, Dr Kieran and Petrie, Professor Mark |
| Authors: | Docherty, K. F., and Petrie, M. C. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| Journal Name: | Heart |
| Publisher: | BMJ Publishing Group |
| ISSN: | 1355-6037 |
| ISSN (Online): | 1468-201X |
| Published Online: | 14 June 2021 |
| Copyright Holders: | Copyright © 2021 The Authors |
| First Published: | First published in Heart 108(4): 312-320 |
| Publisher Policy: | Reproduced in accordance with the publisher copyright policy |
University Staff: Request a correction | Enlighten Editors: Update this record
Funder and Project Information
Funder and Project Information